Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Global thrombosis drug market expected to generate revenue of around USD 40934.75 million by end of 2024, growing at a CAGR of around 9.3% between 2018 and 2024. Thrombosis is a blood clot in the veins or arteries obstructing the blood flow in the circulatory system. It may be formed due to injury or some other reasons.

14-Sep-2018 | Number of pages: 110 | Report Code: ZMR-3363 | Report Format : | Status : Published

Analysis

Thrombosis is a condition in which blood gets a clot in the blood vessel, which leads to the obstruction of blood flow in the circulatory system and it may travel to the other body parts. Thrombosis drugs are those drugs which are used to treat the blood clots formed in the blood arteries and veins. These drugs generally include anticoagulant drugs and thrombin inhibitor drugs which dilute the blood and dissolve the blood clot in the arteries and veins and also reduce the chances of embolism. These drugs are available in the form of a capsule, tablet, and injection. As per the Center for Disease Control and Prevention report 2015, the exact number of people diagnosed with deep vein thrombosis or pulmonary embolism is not known, although it is estimated that 900,000 people could be affected (1 to 2 per 1,000) each year in the United States.

The major factors driving the growth of thrombosis drug market are increased the prevalence of thrombosis coupled with the availability of new products. As per the International Society on Thrombosis and Haemostasis report every year, there are approximately 10 million cases of venous thromboembolism recorded worldwide. There are various companies which are constantly working for the development of various new and effective drugs which is expected to provide better results as compared to conventional drugs. The companies have research and development department which helps in the development of these drugs and further launch of new drugs in the area of treatment are further expected to promote the growth of thrombosis treatment market. Moreover, unmet needs of people and significant technological advancements in the healthcare sectors and new product launches are expected to fuel the growth of thrombosis drug market. However, increased use of generic drugs is expected to hamper the growth of thrombosis drug market over the forecast period.

Global Thrombosis Drug Market

Thrombosis drug market is segmented on the basis of drug class such as Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor. Factor Xa Inhibitor segment is expected to dominate the thrombosis drug market over the forecast period. Based on the indication, the thrombosis drug market is segmented into pulmonary embolism, atrial fibrillation, and deep vein thrombosis. Pulmonary embolism is expected to dominate the thrombosis drug market in the near future. Based on the distribution channel, the thrombosis drug market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Over the forecast period, hospital pharmacies are expected to dominate the thrombosis drug market.

Based on the region, the global thrombosis drug market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the thrombosis drug market in the near future which is closely followed by Europe owing to the various technological advancement and increased prevalence of thrombosis. The Asia Pacific is expected to expand moderately over the forecast period. Latin America and the Middle East & Africa are expected to develop considerably. 

Some of the major key players of thrombosis drug market include GlaxoSmithKline Plc., Aspen Pharmacare Holdings Limited, Johnson & Johnson, Sanofi, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Baxter International Inc., and Pfizer, Inc., among others.


Related Reports

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Hyperhidrosis Treatment Market: By Treatment Type (Botulinum Toxin A, Non-Surgical Microwave Energy Destruction of Sweat Glands, Iontophoresis, Topical Treatments, Surgical Treatments, and Others), By Type (Axillary Hyperhidrosis, Plantar Hyperhidrosis, Palmar Hyperhidrosis, and Others), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Jan-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5214 | Report Format:

The report includes Revenue forecast analysis of the hyperhidrosis treatment market on a global as well as regional level. It also offers historic data of 2016 and 2017 and provides a valuation of the industry surge during 2019-2025 in terms of USD Billion. Our study includes competitive strategi...Read More

Home Blood Pressure Monitoring Devices Market: by Product (Upper Arm Monitors, Wrist Monitors, and Accessories), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 130 | Report Code: ZMR-5131 | Report Format:

According to the report, global demand for home blood pressure monitoring devices market was valued at USD 1,093.1 million in 2018, and is expected to generate revenue of USD 1,611.3 million by end of 2025, growing at a CAGR of 5.7% between 2019 and 2025 The report covers forecast and analysis f...Read More

Orthostatic Hypotension Drugs Market: by Diagnostic Test Type (ECG, Blood Tests, Stress Test and Other), Drug Type (Midodrine, Northera (droxidopa), Fludrocortisone, Caffeine and Others) and End user (Hospitals, ASCs and Clinics and Others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5123 | Report Format:

The report covers forecast and analysis for the Orthostatic Hypotension Drugs market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Orthosta...Read More

Carcinoembryonic Antigen Market: by Application (Thyroid Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Gastrointestinal Cancer and Other Applications); by End User (Research and Academic Institutes, Diagnostic Centers, Hospitals and Other End Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Dec-2019 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5122 | Report Format:

The report covers forecast and analysis for the carcinoembryonic antigen market on a global and regional level. The study provides historic data from 2016 along with forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the carcinoembryonic antige...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.